Riskpilot← Back to searchSign inGet full accessRevenio Group Oyj
OYJActiveY-tunnus 1700625-7Härkähaankuja 7Manufacture of instruments and appliances for measuring, testing and navigation · NACE 2651Est. 2001— employees
Revenue 2024
EUR 1,3M
+50% vs 2023
EBITDA margin
-274.9%
+8% vs 2023
Equity ratio
90.2%
Financial strength
Net profit 2024
EUR 15,5M
-21% vs 2023
| Revenue | EUR 1,3M | +50% |
| EBITDA | EUR -3,5M | +8% |
| Net profit | EUR 15,5M | -21% |
| Total assets | EUR 116M | +1% |
| Equity | EUR 104,6M | +5% |
| Employees | — | — |
Legal name
Revenio Group Oyj
Y-tunnus number
1700625-7
Legal form
Julkinen osakeyhtiö
NACE code
2651 · Manufacture of instruments and appliances for measuring, testing and navigation
Founded
4. huhtikuuta 2001
Share capital
EUR 5 314 919
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on terveydenhuoltoon ja terveysteknologiaan liittyvien laitteiden, tuotteiden, menetelmien ja palveluiden kauppa, välittäminen, tutkimus, tuotekehitys, kaupallistaminen ja markkinointi, terveydenhuoltoon liittyvä koulutus, konsultointi sekä asiantuntijapalveluiden myynti sekä muu terveydenhuoltoalaan liittyvä tai siihen verrattava liiketoiminta. Yhtiö voi toimia konsernin emoyhtiönä ja tuottaa hallintopalveluita, harjoittaa myös muuta liiketoimintaa sekä omistaa ja hallita kiinteistöjä ja arvopapereita sekä muita rahoitusinstrumentteja sekä käydä niillä kauppaa. Yllämainittua toimintaa yhtiö voi harjoittaa joko suoraan tai tytär- ja osakkuusyrityksiä käyttäen.
Address
Härkähaankuja 7
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 744 | 1 184 | 1 483 | 848 | 1 269 |
| Staff expenses | −1 196 | −812 | −2 117 | −1 664 | −2 037 |
| EBITDA | −2 051 | −2 587 | −3 418 | −3 788 | −3 488 |
| Depreciation & amort. | −9 | −33 | −43 | −39 | −30 |
| EBIT | −2 060 | −2 620 | −3 462 | −3 827 | −3 518 |
| Net financials | 1 372 | 1 371 | 1 340 | 991 | 1 854 |
| Profit before tax | 13 655 | 14 598 | 17 687 | 24 532 | 19 436 |
| Tax | −0 | −0 | −0 | 4 915 | 3 892 |
| Net profit | 13 655 | 14 598 | 17 687 | 19 618 | 15 544 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 104 584 | 106 202 | 110 834 | 114 486 | 116 026 |
| Equity | 74 138 | 80 512 | 89 162 | 99 208 | 104 646 |
| Long-term debt | 22 047 | 49 | 14 297 | 10 050 | 5 850 |
| Short-term debt | 8 399 | 25 641 | 7 374 | 5 229 | 5 530 |
| Total debt | 30 446 | 25 690 | 21 671 | 15 279 | 11 380 |
EBITDA margin
-274.9%
This company
15.8%
Market median
-1840% vs market
20202024
Equity ratio
90.2%
This company
38.2%
Market median
+136% vs market
20202024
Return on equity
14.9%
This company
18.4%
Market median
+19% vs market
20202024
Net profit margin
1225.1%
This company
8.1%
Market median
+15025% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JE Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (5) | ||
MK | Audit | 2017 – 2020 |
MP | Audit | 2020 – 2023 |
RA Confidential Clerk | Confidential Clerk | 2017 – 2026 |
TT Chief Executive Officer | Chief Executive Officer | 2019 – 2020 |
MP Chief Executive Officer | Chief Executive Officer | 2019 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (7) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2018 | |
| Board of Directors | 2018 | |
| Chairperson | 2025 | |
| Board of Directors | 2022 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Former (3) | ||
| Board of Directors | 2018 – 2020 | |
| Chairperson | 2018 – 2022 | |
| Board of Directors | 2018 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Revenio Group Oyj (this company)
Revenio Italy S.R.L., ItaliaCenterVue S.p.A., ItaliaChina iCare Medical Technology Co. Ltd, KiinaIcare World AustraliaPty Ltd, AustraliaThirona Retina B.V., AlankomaatCT Operations International UK Ltd, Iso-BritanniaRevenio Australia Pty Ltd, AustraliaBoard members of Revenio Group Oyj also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Merja Kristiina Itäniemi | Audit | 0 companies |
| Mikko Petteri Lahtinen | Audit | 0 companies |
| Robin Allan Pulkkinen | Confidential Clerk | 0 companies |
| Timo Tapio Hildén | Chief Executive Officer | 0 companies |
| Mikko Petteri Moilanen | Chief Executive Officer | 0 companies |
| Jouni Erik Toijala | Chief Executive Officer | 0 companies |
| Mikael Bill Ivar Östman | Board of Directors | 0 companies |
| Ann-Christine Margareta Sundell | Board of Directors | 0 companies |
| Kari-Pekka Sakari Tammela | Board of Directors | 0 companies |
| Arne Boye Nielsen | Chairperson | 0 companies |
| Ari Tapani Kohonen | Board of Directors | 0 companies |
| Pekka Veikko Juhani Rönkä | Chairperson | 0 companies |
| Kyösti Niilo Juhani Kakkonen | Board of Directors | 0 companies |
| Riad Nassib Sherif | Board of Directors | 0 companies |
| Anat Loewenstein | Board of Directors | 0 companies |
| Heli Maria Lindfors | Board of Directors | 0 companies |